Clark Capital Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,267
| Closed | -$2.86M | – | 477 |
|
|
2025
Q1 | $2.86M | Buy |
+35,267
| New | +$2.86M | 0.02% | 242 |
|
|
2024
Q3 | – | Sell |
-46,488
| Closed | -$4.31M | – | 444 |
|
|
2024
Q2 | $4.31M | Buy |
+46,488
| New | +$4.31M | 0.03% | 182 |
|
|
2023
Q3 | – | Sell |
-41,224
| Closed | -$3.43M | – | 378 |
|
|
2023
Q2 | $3.43M | Buy |
41,224
+269
| +0.7% | +$22.4K | 0.03% | 191 |
|
|
2023
Q1 | $3.12M | Sell |
40,955
-24,797
| -38% | -$1.89M | 0.03% | 188 |
|
|
2022
Q4 | $5.46M | Buy |
65,752
+1,181
| +2% | +$98K | 0.05% | 169 |
|
|
2022
Q3 | $5.12M | Sell |
64,571
-5,444
| -8% | -$432K | 0.07% | 166 |
|
|
2022
Q2 | $5.2M | Buy |
+70,015
| New | +$5.2M | 0.07% | 162 |
|
|
2017
Q4 | – | Sell |
-14,509
| Closed | -$1.26M | – | 334 |
|
|
2017
Q3 | $1.26M | Buy |
+14,509
| New | +$1.26M | 0.04% | 200 |
|